Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail
-

BCG Live (Intravesical)

STN: 103943
Proper Name: BCG Live (Intravesical)
Tradename: TheraCys
Manufacturer: Sanofi Pasteur Limited Lic#1726
Indications:

  • For intravesical use in the treatment and prophylaxis of carcinoma in situ (CIS) of the urinary bladder and for the prophylaxis of primary or recurrent stage Ta and/or T1 papillary tumors following transurethral resection (TUR).
-
-
-
-
-
-